Back to STATE STREET CORP STATE STREET CORP

TSHATSHA
11 quarters

Position history for STATE STREET CORPSTATE STREET CORP's holdings in TAYSHA GENE THERAPIES INC

STATE STREET CORP holds 11.4M shares of TSHA (TAYSHA GENE THERAPIES INC), worth $77.8M as of 2026-Q2. The position was increased (+1.9% shares). TSHA represents 0.0% of STATE STREET CORP's portfolio.

Current Value

$77.8M

Current Shares

11.4M

Total Value Change

+$77.5M

Total Shares Change

+11.3M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
11.4M
+1.9%
$77.8M0.0%$6.81
30
2026-Q1
Increased
11.2M
+3.9%
$50.1M0.0%$4.53
30
2025-Q4
Increased
10.8M
+49.1%
$59.3M0.0%$5.66
41
2025-Q3
Increased
7.2M
+40.8%
$23.7M0.0%$3.16
38
2025-Q2
Increased
5.1M
+58.9%
$11.9M0.0%$2.38
40
2025-Q1
Decreased
3.2M
-50.1%
$4.5M0.0%$1.93
0
2024-Q4
Increased
6.5M
+86.6%
$11.2M0.0%$1.73
43
2024-Q3
Increased
3.5M
+4.5%
$7M0.0%$2.07
29
2024-Q2
Increased
3.3M
+877.4%
$7.4M0.0%$2.24
44
2024-Q1
Increased
339,520
+137.1%
$974,4220.0%$2.87
27
2023-Q4
New
143,220
-
$253,4990.0%$1.77
35

Other major holders of TSHA: Avoro Capital Advisors LLC, RA CAPITAL MANAGEMENT, L.P., GOLDMAN SACHS GROUP INC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used